**INTRODUCTION:** Nerbridge^TM^ (Toyobo Co., Ltd., Osaka, Japan) is a resorbable, artificial nerve conduit with polyglycolic acid tubing and a collagenous interior. It is the only such device currently approved in Japan. Nerbridge^TM^ is mainly used in clinical practice to bridge peripheral nerves after traumatic nerve injury, but there are few reports on its application in reconstruction and repair of the facial nerve. In the present study, we evaluated the utility of Nerbridge^TM^ to promote nerve regeneration in a murine model of injury to the buccal branch of the facial nerve.

**METHODS:** Under inhalational anesthesia and microscopic guidance, we exposed the buccal branch of the left facial nerve in 8-week-old Lewis rats and created a 7-mm gap in the nerve. The gap was then bridged with either Nerbridge^TM^ of length 1 cm or with an autologous nerve graft (AG). At 13 weeks after the procedure, tissue samples were collected from both groups of rats and compared using Toluidine blue staining and electron microscopy.

**RESULTS:** Mean nerve fiber diameter in the central region of the regenerated nerve was not significantly different between AG and Nerbridge^TM^ rats (5.39 ± 2.42 μm vs. 4.88 ± 1.44 μm). However, myelin width differed significantly between both groups (0.82 ± 0.45 μm vs. 0.45 ± 0.12 μm). Also, AG rats showed significantly greater improvement in g-ratio, an index of nerve maturation, (0.70 ± 0.12 mm vs. 0.82 ± 0.04 mm).

**CONCLUSION:** This study demonstrates the utility of Nerbridge^TM^ for facial nerve reconstruction following nerve injury. However, when used alone, the capacity of Nerbridge^TM^ to promote nerve regeneration was inferior to that of AG. Therefore, future research is needed to investigate the use of Nerbridge^TM^ in conjunction with stem cell and growth factor delivery systems to achieve effectiveness comparable to that of AG.
